Catherine Stehman-Breen

Insider Reports History

Entity
Individual
Location
215 First Street, Suite 415, Cambridge, Massachusetts
Signature
/s/ Shawna-Gay White, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Catherine Stehman-Breen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Generation Bio Co. Director Stock Option (right to buy) 60 K $275 K $4.59 Jun 6, 2024 Direct
Tenaya Therapeutics, Inc. Director Stock Option (Right to buy) 29.5 K Jun 9, 2023 Direct
Dyne Therapeutics, Inc. Director Stock option (right to buy) 25.1 K May 22, 2024 Direct

Insider Reports Filed by Catherine Stehman-Breen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GBIO Generation Bio Co. Jun 6, 2024 1 $0 4 Jun 10, 2024 Director
DYN Dyne Therapeutics, Inc. May 22, 2024 1 $0 4 May 24, 2024 Director
TNYA Tenaya Therapeutics, Inc. Jun 9, 2023 1 $0 4 Jun 12, 2023 Director
GBIO Generation Bio Co. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
DYN Dyne Therapeutics, Inc. May 24, 2023 1 $0 4 May 25, 2023 Director
DYN Dyne Therapeutics, Inc. Jul 5, 2022 1 $0 4 Jul 6, 2022 Director
TNYA Tenaya Therapeutics, Inc. Jun 10, 2022 1 $0 4 Jun 13, 2022 Director
GBIO Generation Bio Co. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
DYN Dyne Therapeutics, Inc. Jun 3, 2022 1 $0 4 Jun 6, 2022 Director
TNYA Tenaya Therapeutics, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 Director
GBIO Generation Bio Co. Jun 9, 2021 1 $0 4 Jun 11, 2021 Director
DYN Dyne Therapeutics, Inc. May 26, 2021 1 $0 4 May 27, 2021 Director